Related Experiment Video
Updated: Jun 22, 2025

06:54
Author Spotlight: Enhanced Method for Evaluating Analgesic Effects — Dual Hind Paw Carrageenan Injection in Mice
Published on: November 15, 2024
1.4K
Exploring the bidirectional causal associations between pain and circulating inflammatory proteins: A Mendelian
Yu Wang1, Wenyu Zhou2, Faqiang Zhang2
1Department of Anesthesiology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Clinical and Experimental Pharmacology & Physiology
|July 5, 2024
Summary
This study reveals that circulating inflammatory proteins causally influence multisite chronic pain (MCP) and site-specific chronic pain (SSCP). Specific proteins offer protective effects or act as risk factors, guiding potential therapeutic strategies for pain management.
Area of Science:
- Genetics and Molecular Biology
- Immunology
- Pain Medicine
Background:
- Chronic pain, both multisite (MCP) and site-specific (SSCP), may be linked to circulating inflammatory proteins.
- The precise causal relationship between these proteins and various chronic pain conditions remains largely unknown.
Purpose of the Study:
- To investigate the potential causal relationships between 91 circulating inflammatory proteins and MCP and SSCP using Mendelian randomization.
- To identify specific inflammatory proteins that may act as protective factors or risk factors for different types of chronic pain.
Main Methods:
- A two-sample bidirectional Mendelian randomization (MR) analysis was employed.
- Data from 91 circulating inflammatory proteins, MCP, and SSCP (including headache, back, shoulder, hip, knee, abdominal, and facial pain) were analyzed.
- Inverse variance weighting was the primary MR method, supplemented by sensitivity analyses (weighted median, MR-PRESSO, Egger intercept) and heterogeneity tests (Cochrane's Q, leave-one-out).
Main Results:
- A causal relationship was established between 29 circulating inflammatory proteins and chronic pain conditions.
- Fourteen proteins demonstrated a protective effect against MCP and SSCP, while 15 proteins were identified as risk factors.
- Importantly, MCP and SSCP did not show a significant causal impact on circulating inflammatory protein levels.
Conclusions:
- Specific circulating inflammatory proteins have a causal influence on the development and progression of MCP and SSCP.
- These findings highlight potential therapeutic targets for managing chronic pain conditions.
- The study provides a foundation for developing novel treatments by modulating inflammatory protein pathways.
Related Concept Videos
Nociception
27.8K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
27.8K
The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K
Analgesia and Pain Management
568
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
568

